natl cons survey letter

natl cons survey letter.doc

National Consumer Surveys on Understanding the Risks and Benefits of FDA-Regulated Medical Products

natl cons survey letter

OMB: 0910-0698

Document [doc]
Download: doc | pdf

DATE


Screening ID #

Resident

[STREET ADDRESS] [MULTI UNIT]

[CITY], [ST] [ZIP]


Dear [City] Resident:


I am writing to ask for your help with an important survey being conducted for the U.S. Food and Drug Administration (FDA). This survey will help the FDA better understand how people think about communications related to the drugs, devices, and other medical products that it regulates.


Your household has been randomly selected to participate in this survey. This letter is addressed to “Resident” because all households, including yours, were selected based on the address listed. The FDA does not know for sure who lives at the address, but it values your opinions as being representative of others in your area.


RTI International, a non-profit research company, is conducting this survey for FDA. In the next few weeks, RTI will call your household to ask a few simple questions to determine if your household is eligible for the survey. RTI will also provide more information about the survey to help you decide whether or not you would like to participate.


If you think we might not have the correct telephone information for you, please call 1-XXX-XXX-XXXX to provide it. Your phone number will NOT be used for any other purpose than this survey. It will not be sold or shared, and it will be deleted after the study is finished in 2012.


If you decide to participate, your identity and responses will be kept completely private. We are required by Federal law to keep the study information secure, and we have taken steps to make sure we carefully protect your information. No individual information will be reported back to the FDA or any other individual, agency, or organization.


If you have any questions about the study, you may contact a study team member toll-free at 1-XXX-XXX-XXXX.


Your help is extremely important to the success of this study. Thank you in advance for your cooperation.


Sincerely,




FDA Official TBD


File Typeapplication/msword
File TitleLETTERHEAD HERE: RTI
AuthorYChiang
Last Modified Byjcapezzu
File Modified2011-06-16
File Created2011-06-16

© 2024 OMB.report | Privacy Policy